308 related articles for article (PubMed ID: 29310330)
1. Can catheter ablation reduce the incidence of thromboembolic events in patients with atrial fibrillation?: Protocol for a systematic review and meta-analysis.
Liu M; Wang Y; Chen X; Li X; Zhuang X; Wang L
Medicine (Baltimore); 2017 Dec; 96(48):e8479. PubMed ID: 29310330
[TBL] [Abstract][Full Text] [Related]
2. Opposite effect of ablation on early/late-phase thromboembolic incidence in patients with atrial fibrillation: A meta-analysis on more than 100 000 individuals.
Liu M; Wang Y; Li J; Zhuang X; Chen X; Li X; Liao X; Wang L
Clin Cardiol; 2020 Jun; 43(6):594-605. PubMed ID: 32159241
[TBL] [Abstract][Full Text] [Related]
3. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
[TBL] [Abstract][Full Text] [Related]
4. Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis.
Toso E; Peyracchia M; Matta M; D'Ascenzo F; Gaita F; Kornej J; Hindricks G; Jared Bunch T; Saliba W
Int J Cardiol; 2018 Nov; 270():172-179. PubMed ID: 29945808
[TBL] [Abstract][Full Text] [Related]
5. Thromboembolic risk and anticoagulation strategies in patients undergoing catheter ablation for atrial fibrillation.
Viles-Gonzalez JF; Mehta D
Curr Cardiol Rep; 2011 Feb; 13(1):38-42. PubMed ID: 21057900
[TBL] [Abstract][Full Text] [Related]
6. Incidence of late thromboembolic events after catheter ablation of atrial fibrillation.
Yagishita A; Takahashi Y; Takahashi A; Fujii A; Kusa S; Fujino T; Nozato T; Kuwahara T; Hirao K; Isobe M
Circ J; 2011; 75(10):2343-9. PubMed ID: 21778595
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation.
Sardar P; Nairooz R; Chatterjee S; Wetterslev J; Ghosh J; Aronow WS
Am J Cardiol; 2014 Apr; 113(7):1173-7. PubMed ID: 24513472
[TBL] [Abstract][Full Text] [Related]
8. Apixaban for periprocedural anticoagulation during catheter ablation of atrial fibrillation: a systematic review and meta-analysis of 1691 patients.
Blandino A; Bianchi F; Biondi-Zoccai G; Grossi S; Conte MR; Rametta F; Gaita F
J Interv Card Electrophysiol; 2016 Sep; 46(3):225-36. PubMed ID: 27217030
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation after catheter ablation of atrial fibrillation guided by implantable cardiac monitors.
Zuern CS; Kilias A; Berlitz P; Seizer P; Gramlich M; Müller K; Duckheim M; Gawaz M; Schreieck J
Pacing Clin Electrophysiol; 2015 Jun; 38(6):688-93. PubMed ID: 25753968
[TBL] [Abstract][Full Text] [Related]
10. Surgical ablation of atrial fibrillation: a protocol for a systematic review and meta-analysis of randomised controlled trials.
McClure GR; Belley-Cote EP; Singal RK; Jaffer IH; Dvirnik N; An KR; Fortin G; Spence J; Whitlock RP
BMJ Open; 2016 Nov; 6(11):e013273. PubMed ID: 27807090
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta-analysis.
Ge Z; Faggioni M; Baber U; Sartori S; Sorrentino S; Farhan S; Chandrasekhar J; Vogel B; Qadeer A; Halperin J; Reddy V; Dukkipati S; Dangas G; Mehran R
Cardiovasc Ther; 2018 Oct; 36(5):e12457. PubMed ID: 29971964
[TBL] [Abstract][Full Text] [Related]
12. Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.
Swaans MJ; Alipour A; Rensing BJ; Post MC; Boersma LV
J Vis Exp; 2013 Feb; (72):e3818. PubMed ID: 23486416
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.
Bin Abdulhak AA; Khan AR; Tleyjeh IM; Spertus JA; Sanders SU; Steigerwalt KE; Garbati MA; Bahmaid RA; Wimmer AP
Europace; 2013 Oct; 15(10):1412-20. PubMed ID: 23954918
[TBL] [Abstract][Full Text] [Related]
14. Left atrial appendage morphology and thromboembolic risk after catheter ablation for atrial fibrillation.
Nedios S; Kornej J; Koutalas E; Bertagnolli L; Kosiuk J; Rolf S; Arya A; Sommer P; Husser D; Hindricks G; Bollmann A
Heart Rhythm; 2014 Dec; 11(12):2239-46. PubMed ID: 25128733
[TBL] [Abstract][Full Text] [Related]
15. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of catheter ablation combined with left atrial appendage occlusion for nonvalvular atrial fibrillation: A systematic review and meta-analysis.
Jiang Y; Li F; Li D; Cheng Y; Jia Y; Fu H; Pu X; Hu H; Jiang J; Zeng R
Pacing Clin Electrophysiol; 2020 Jan; 43(1):123-132. PubMed ID: 31721242
[TBL] [Abstract][Full Text] [Related]
17. Stroke and Cardiovascular Events After Ablation or Antiarrhythmic Drugs for Treatment of Patients With Atrial Fibrillation.
Mansour M; Heist EK; Agarwal R; Bunch TJ; Karst E; Ruskin JN; Mahapatra S
Am J Cardiol; 2018 May; 121(10):1192-1199. PubMed ID: 29571722
[TBL] [Abstract][Full Text] [Related]
18. Lower Major Bleeding Rates with Direct Oral Anticoagulants in Catheter Ablation of Atrial Fibrillation: an Updated Meta-analysis of Randomized Controlled Studies.
Brunetti ND; Tricarico L; Tilz RR; Heeger CH; De Gennaro L; Correale M; Ieva R; Di Biase M; Rillig A; Metzner A; Santoro F
Cardiovasc Drugs Ther; 2020 Apr; 34(2):209-214. PubMed ID: 32080786
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
[TBL] [Abstract][Full Text] [Related]
20. Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: A systematic review and meta-analysis.
Romero J; Cerrud-Rodriguez RC; Diaz JC; Rodriguez D; Arshad S; Alviz I; Cerna L; Rios S; Monhanty S; Natale A; Garcia MJ; Di Biase L
J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1250-1257. PubMed ID: 31257677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
